In conclusion, a germline predisposition to myeloid neoplasms occurred in ~16% of young-onset MDS patients and was largely associated with primary immunodeficiencies, including GATA2 deficiency. The gene discussed is GATA2; the disease is hyperinsulinemic hypoglycemia, familial, 4.